{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:08:32Z","timestamp":1793452112911,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.atherosclerosis.2012.02.019","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T06:40:33Z","timestamp":1329374433000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":302,"title":["Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment"],"prefix":"10.1016","volume":"223","author":[{"given":"Frederick J.","family":"Raal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0005","first-page":"49","article-title":"Familial hypercholesterolaemia","volume":"25","author":"Marais","year":"2004","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0010","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2863","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0015","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI200318925","article-title":"Monogenic hypercholesterolemia: new insights in pathogenesis and treatment","volume":"111","author":"Rader","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.281.6241.633","article-title":"A\u00a0host of hypercholesterolaemic homozygotes in South Africa","volume":"281","author":"Seftel","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.9.2.211","article-title":"Homozygous familial hypercholesterolemia among French Canadians in Quebec Province","volume":"9","author":"Moorjani","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2010.11.006","article-title":"Homozygous familial hypercholesterolemia in Lebanon: a genotype\/phenotype correlation","volume":"102","author":"Fahed","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2010.11.005","article-title":"Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan","volume":"214","author":"Mabuchi","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0040","first-page":"731","article-title":"Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia","volume":"76","author":"Haitas","year":"1990","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9150(97)00168-8","article-title":"Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia","volume":"135","author":"Raal","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9150(99)00435-9","article-title":"Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia","volume":"150","author":"Raal","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0055","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.0000018744.58460.62","article-title":"Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia","volume":"105","author":"Gagne","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11883-002-0058-7","article-title":"Statins in homozygous familial hypercholesterolemia","volume":"4","author":"Marais","year":"2002","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0065","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.atherosclerosis.2007.06.028","article-title":"A\u00a0dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia","volume":"197","author":"Marais","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0075","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.atherosclerosis.2007.08.017","article-title":"Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography","volume":"197","author":"Santos","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0080","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0085","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","article-title":"Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Hopkins","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.mol.0000137222.23784.2a","article-title":"Current management of severe homozygous hypercholesterolaemias","volume":"15","author":"Naoumova","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0100","doi-asserted-by":"crossref","first-page":"RRN1238","DOI":"10.1371\/currents.RRN1238","article-title":"Cascade screening for familial hypercholesterolemia (FH)","volume":"3","author":"Ned","year":"2011","journal-title":"PLoS Curr"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0105","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1373\/clinchem.2005.055228","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia","volume":"51","author":"Holmes","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0110","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.atherosclerosis.2011.08.039","article-title":"Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality","volume":"219","author":"Versmissen","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11748-008-0335-7","article-title":"Triple coronary artery bypass graft in a 10-year-old child with familial hypercholesterolemia","volume":"57","author":"Nemati","year":"2009","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9149(97)89309-5","article-title":"Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia","volume":"77","author":"Schmidt","year":"1996","journal-title":"Am J Cardiol"},{"issue":"Suppl.","key":"10.1016\/j.atherosclerosis.2012.02.019_bib0125","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","article-title":"PCSK9: a convertase that coordinates LDL catabolism","volume":"50","author":"Horton","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpeds.2010.06.027","article-title":"Sudden death in a 4-year-old boy: a near-complete occlusion of the coronary artery caused by an aggressive low-density lipoprotein receptor mutation (W556R) in homozygous familial hypercholesterolemia","volume":"158","author":"Widhalm","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0135","first-page":"363","article-title":"Bilateral carotid atherosclerosis: an inevitable consequence of homozygous familial hypercholesterolemia","volume":"20","author":"Nemati","year":"2011","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1526-0968.2003.00075.x","article-title":"Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis","volume":"7","author":"Kawaguchi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.107.160408","article-title":"Vascular calcifications in homozygote familial hypercholesterolemia","volume":"28","author":"Awan","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.98.6.509","article-title":"Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia","volume":"98","author":"Summers","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-7-7","article-title":"Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia","volume":"7","author":"Zech","year":"2008","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2010.10.001","article-title":"Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia","volume":"213","author":"Miname","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0165","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.atherosclerosis.2011.09.052","article-title":"Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia","volume":"219","author":"Neefjes","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum Mutat"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0175","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2005.11.016","article-title":"Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison","volume":"188","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ejhg.2008.138","article-title":"LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance","volume":"17","author":"Snozek","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1567-5688(09)71802-1","article-title":"Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R","volume":"10","author":"Soufi","year":"2009","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1755-8794-1-60","article-title":"Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism","volume":"1","author":"Mosig","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11745-002-0915-1","article-title":"Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels","volume":"37","author":"Scanu","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0200","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0205","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.jacl.2011.03.451","article-title":"Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Robinson","year":"2011","journal-title":"J\u00a0Clin Lipid"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.14.99","article-title":"Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia","volume":"14","author":"Davis","year":"2007","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0215","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2008.02.009","article-title":"Recommendations for the use of LDL apheresis","volume":"198","author":"Thompson","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.atherosclerosis.2009.06.010","article-title":"Efficacy criteria and cholesterol targets for LDL apheresis","volume":"208","author":"Thompson","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00251-4","article-title":"LDL apheresis","volume":"167","author":"Thompson","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0235","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0b013e3283402f53","article-title":"Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe","volume":"21","author":"Thompson","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0240","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1111\/j.1399-3046.2010.01383.x","article-title":"Preemptive liver transplantation in a child with familial hypercholesterolemia","volume":"15","author":"Maiorana","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1399-3046.2010.01458.x","article-title":"Liver transplantation as treatment for familial homozygous hypercholesterolemia: too early or too late","volume":"15","author":"Malatack","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0250","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1345\/aph.1K065","article-title":"ISIS 301012 gene therapy for hypercholesterolemia: sense, antisense, or nonsense?","volume":"41","author":"Ito","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0255","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0260","article-title":"PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates","author":"Lindholm","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.111.187419","article-title":"Proprotein convertase substillisin\/kexin type 9 reduces LDL-cholesterol in statin-treated hypercholesterolemic nonhuman primates","volume":"340","author":"Liang","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.atherosclerosis.2012.02.019_bib0270","unstructured":"Sanofi and Regeneron report positive preliminary phase 2 program results for anti-PCSK9 antibody in hypercholesterolemia [press release]. Paris and Tarrytown, NY: PRNewswire; November 10, 2011."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:33:56Z","timestamp":1758155636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0021915012001335"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.02.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}